Carina Tudor-Sfetea
1
* , BSc (Hons), MSc ;
Riham Rabee
2
* , BSc (Hons), MBBS ;
Muhammad Najim
3
* , BSc (Hons), MBBS ;
Nima Amin
3
, BSc (Hons) ;
Mehak Chadha
4
, BSc (Hons) ;
Minal Jain
4
, BSc (Hons) ;
Kishan Karia
3
, BSc (Hons) ;
Varun Kothari
3
, BSc (Hons) ;
Tejus Patel
4
, BSc (Hons) ;
Melanie Suseeharan
3
, BSc (Hons) ;
Maroof Ahmed
1
, BSc (Hons), MBBS ;
Yusuf Sherwani
1
, BSc (Hons), MBBS ;
Sarim Siddiqui
1
, BSc (Hons), MBBS ;
Yuting Lin
4
, BBA (Hons), MS ;
Andreas B Eisingerich
4
, BSc (Hons), MPhil, PhD
1
Digital Therapeutics, London, United Kingdom
2
Barts and The London School of Medicine and Dentistry, London, United Kingdom
3
Department of Medicine, Faculty of Medicine, Imperial College London, London, United Kingdom
4
Imperial College Business School, Imperial College London, London, United Kingdom
*these authors contributed equally
Corresponding Author:
-
Andreas B Eisingerich, BSc (Hons), MPhil, PhD
-
Imperial College Business School
-
Imperial College London
-
South Kensington Campus
-
Ayrton Rd, Kensington
-
London, SW7 2AZ
-
United Kingdom
-
Phone:
44 020 7589 5111
-
Email: a.eisingerich@imperial.ac.uk